Cardiovascular Devices Market Report 2024: Strategies And Recent Developments | Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Cardiovascular Devices Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The cardiovascular devices market size has grown strongly in recent years. It will grow from $66.15 billion in 2023 to $72.15 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to lifestyle-related diseases, aging population, minimally invasive procedures and implantable devices, healthcare access, regulatory approvals.

The cardiovascular devices market size is expected to see strong growth in the next few years. It will grow to $98.57 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to personalized medicine, remote monitoring, emerging markets growth, artificial intelligence (AI) integration, value-based healthcare. Major trends in the forecast period include wearable cardiovascular devices, minimally invasive interventions, bioresorbable devices, remote consultations and telesurgery, sustainable and eco-friendly devices.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=1972&type=smp

Market Segmentation:
The main types in the cardiovascular devices market are cardiovascular surgery devices and equipment, cardiac rhythm management (CRM) devices and equipment, interventional cardiology devices and equipment, defibrillator devices and equipment, peripheral vascular devices and equipment, prosthetic heart valve devices and equipment, electrophysiology devices and equipment, and cardiac assist devices and equipment. Defibrillators are devices that restore the normal heartbeat by sending an electric pulse or shock to the heart. They are used to prevent or correct an arrhythmia, a heartbeat that is uneven or slow or fast. The type of expenditure is public, or private. The products used are instruments/equipment, and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others.

Major Driver - Rising Prevalence Of Cardiovascular Disorders Fuels Growth In The Cardiovascular Device Market
An increase in the prevalence of cardiovascular disorders contributes to the growth of the cardiovascular device market. Cardiovascular disorders refer to a group of medical conditions that affect the heart and blood vessels, encompassing various diseases and disorders that involve the circulatory system. A cardiovascular device is a device used to support heart function and blood flow in people with weak or failing hearts. For instance, in June 2023, according to the Immigration and Checkpoints Authority, a Singapore-based government agency, there were 6,884 deaths attributed to heart and hypertensive diseases in 2022, an increase of 10.35% compared to 6,238 deaths recorded in 2021. Therefore, the increase in the prevalence of cardiovascular disorders is expected to drive the growth of the cardiovascular device market.

Competitive Landscape:
Major companies operating in the cardiovascular devices market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton, Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologie Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Danaher Corporation, Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W L Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE and Co. KG, CeloNova BioSciences Inc., LeMaitre Vascular Inc., Nano Therapeutics Pvt. Ltd.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Top Trend - Leading Cardiovascular Device Companies Enhance Profitability With Innovative Heliostar Balloon Ablation Catheter
Major companies operating in the cardiovascular devices market are launching new products, such as the balloon ablation catheter, to increase their profitability in the market. The balloon ablation catheter is the initial radiofrequency balloon ablation catheter designed for catheter-based cardiac electrophysiological mapping, involving both stimulation and recording of the atria. For instance, in October 2022, Biosense Webster, a US-based company operating in the science of diagnosing and treating heart rhythm disorders, launched the HELIOSTAR Balloon Ablation Catheter. The HELIOSTAR Balloon Ablation Catheter features exclusive one-shot balloon technology that allows for pulmonary vein isolation in just 12 seconds, complete with tailored energy delivery and an integrated 3D mapping solution.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Cardiovascular Devices Market Characteristics
3. Cardiovascular Devices Market Trends And Strategies
4. Cardiovascular Devices Market - Macro Economic Scenario
5. Cardiovascular Devices Market Size And Growth
…..
27. Cardiovascular Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.